IOVApproval•globenewswire•
Iovance’s Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma
Sentiment:Positive (80)
Summary
First T cell therapy for a solid tumor cancer and first treatment option approved in Canada for advanced melanoma after anti-PD-1 and targeted therapy
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 18, 2025 by globenewswire